RHABDOID TUMOR OF THE KIDNEY
Clinical trials for RHABDOID TUMOR OF THE KIDNEY explained in plain language.
Never miss a new study
Get alerted when new RHABDOID TUMOR OF THE KIDNEY trials appear
Sign up with your email to follow new studies for RHABDOID TUMOR OF THE KIDNEY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo shows promise in advanced kidney cancer trial
Disease control OngoingThis phase 3 trial tests whether adding the drug cabozantinib to standard immunotherapy (nivolumab and ipilimumab) helps people with advanced kidney cancer live longer. About 1,175 adults with kidney cancer that has spread will take part. The goal is to see if the combination wor…
Matched conditions: RHABDOID TUMOR OF THE KIDNEY
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 10:07 UTC
-
Immunotherapy combo shows promise for Tough-to-Treat childhood tumors
Disease control OngoingThis study is testing whether combining two immunotherapy drugs, nivolumab and ipilimumab, can shrink or control rare INI1-negative cancers in children and young adults. These cancers have come back or not responded to standard treatments. The goal is to see if the drugs help the…
Matched conditions: RHABDOID TUMOR OF THE KIDNEY
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 26, 2026 10:05 UTC